Cardiac Magnetic Resonance in Children With Muscular Dystrophy

PITT0110 - Cardiac Magnetic Resonance: A Parallel Protocol to Cardiac Outcome Measures in Children With Muscular Dystrophy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01081080

Enrollment

Registered

2010-03-05

Start date

2010-04-30

Completion date

2011-10-31

Last updated

2013-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Becker Muscular Dystrophy, Duchenne Muscular Dystrophy, Limb Girdle Muscular Dystrophy

Keywords

cardiac, muscle, pediatric, dystrophy

Brief summary

This protocol will exploit novel state of the art cardiovascular magnetic resonance techniques to examine important changes in the heart in children with muscular dystrophy. The purpose of this study is to compare cardiac magnetic resonance (CMR) with the collected cardiac outcome data obtained in protocol: PITT1109 - Cardiac Outcome Measures in Children with Muscular Dystrophy.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

8 Years to 18 Years

Healthy volunteers

Inclusion criteria

* Participant enrolled in the CINRG study: PITT1109 - Cardiac Outcome Measures in Children with Muscular Dystrophy

Exclusion criteria

* Pregnant woman (when uncertain, participants will undergo urine testing) or lactating women * Decompensated congestive heart failure (unable to lie flat during CMR) * Impaired renal excretory function (calculated Glomerular Filtration Rate less than 30mL/min) * Contra-indications to Magnetic Resonance Imaging: * Cardiac pacemaker or implantable defibrillator * Cerebral aneurysm clip * Neural stimulator * Metallic ocular foreign body * Harrington-rod * Any implanted device (i.e. insulin pump, drug infusion device) * Claustrophobia * Metal shrapnel or bullet

Countries

United States

Outcome results